Azenta, Inc. Logo

Azenta, Inc.

Life science solutions for pharma & biotech, offering sample management, storage & multiomics.

AZTA | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
200 SUMMIT DRIVE, 1803 BURLINGTON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Azenta, Inc. is a global provider of integrated life sciences solutions designed to accelerate the discovery, development, and delivery of new therapies. The company's portfolio centers on sample lifecycle management, offering a comprehensive suite of products and services that includes automated ultra-cold and cryogenic storage systems, consumables, and informatics software for sample management. Through its GENEWIZ brand, Azenta also provides extensive multiomics and synthesis services, such as next-generation sequencing, Sanger sequencing, and gene synthesis. Serving clients in the pharmaceutical, biotechnology, and academic sectors, Azenta supports critical workflows from research and clinical trials to manufacturing, enabling organizations to bring impactful breakthroughs to market faster.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Azenta, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Azenta, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Azenta, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BeyondSpring Inc. Logo
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America BYSI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.
United States of America BIAF
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea 251120
BioNexus Gene Lab Corp Logo
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
United States of America BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea 086040
Bolt Biotherapeutics, Inc. Logo
Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.
United States of America BOLT
Bonus BioGroup Ltd. Logo
Develops cell therapies and tissue products for bone grafts and inflammation repair.
Israel BONS

Talk to a Data Expert

Have a question? We'll get back to you promptly.